Skip to main content
. 2016 Mar 3;157(5):2104–2115. doi: 10.1210/en.2015-1850

Table 2.

Arterial Values in Ambient, Oxygenated, and Hypoxemic GSIS Studies

Study Period Ambient Oxygen Tension
Oxygenation
Hypoxemia
Intact-Control (n = 7) AD-Control (n = 7) Intact-IUGR (n = 7) AD-IUGR (n = 5) Intact-IUGR (n = 7) AD-IUGR (n = 5) Intact-Control (n = 7) AD-Control (n = 7)
Basal
    O2 content, mmol/L 3.8 ± 0.1a 3.0 ± 0.1b 2.1 ± 0.2c 1.8 ± 0.2c 3.5 ± 0.2d 3.4 ± 0.3d 1.3 ± 0.1d 1.2 ± 0.1d
    PaCO2, mm Hg 47.4 ± 0.5a 51.6 ± 0.6b 51.3 ± 1.3b 54.4 ± 1.1b 49.9 ± 0.9 54.1 ± 1.3 40.9 ± 0.7d 46.4 ± 1.3d,e
    pH 7.30 ± 0.01a,b 7.30 ± 0.01a,b 7.32 ± 0.01a 7.28 ± 0.01b 7.35 ± 0.01d,e 7.29 ± 0.01 7.28 ± 0.01 7.28 ± 0.01
    Hematocrit, % 33.8 ± 0.5a 35.7 ± 1.3a,b 42.5 ± 1.5c 40.9 ± 1.9b,c 38.5 ± 1.7d 37.5 ± 2.0d 36.1 ± 0.4d 37.6 ± 0.9d
    Bicarbonate, mmol/L 21.2 ± 0.3 22.1 ± 0.3 22.2 ± 0.4 21.3 ± 0.3 24.5 ± 0.4d,e 22.1 ± 0.3d 17.5 ± 0.7d 18.6 ± 0.5d
    Lactate, mmol/L 1.62 ± 0.09a 2.68 ± 0.18a,b 2.84 ± 0.19a,b 3.84 ± 0.50b 4.30 ± 0.83d 4.42 ± 0.91 8.15 ± 0.96d 8.20 ± 0.83d
Hyperglycemic
    O2 content, mmol/L 3.5 ± 0.1a,f 2.9 ± 0.1b,f 1.3 ± 0.1c,f 1.6 ± 0.1c,f 2.6 ± 0.2d 3.0 ± 0.3d 1.2 ± 0.1d 1.2 ± 0.1d
    PaCO2, mm Hg 48.5 ± 0.6a 52.4 ± 0.9a,b 54.5 ± 0.8b,f 56.5 ± 1.2b,f 54.5 ± 1.2 56.4 ± 1.2 40.0 ± 0.6d 48.8 ± 1.2d,e
    pH 7.29 ± 0.01a,f 7.29 ± 0.01a,f 7.26 ± 0.01a,b,f 7.25 ± 0.01b,f 7.31 ± 0.01d,e 7.27 ± 0.01 7.16 ± 0.02d 7.16 ± 0.03d
    Hematocrit, % 33.4 ± 0.5a 35.5 ± 1.2a,b 40.9 ± 1.4b 40.2 ± 1.8b 38.2 ± 1.6d 36.9 ± 2.0d 35.0 ± 0.4d 35.7 ± 0.9e
    Bicarbonate, mmol/L 20.6 ± 0.3f 21.5 ± 0.2f 19.9 ± 0.4f 20.0 ± 0.3f 23.1 ± 0.4d 21.7 ± 0.4d 13.3 ± 0.8d 14.9 ± 0.9d
    Lactate, mmol/L 2.18 ± 0.09a,f 3.05 ± 0.15a,f 5.70 ± 0.34b,f 5.23 ± 0.57b,f 4.38 ± 0.62d 4.30 ± 0.76 13.36 ± 1.39d 12.44 ± 1.28d
a-c

Letter superscripts denote differences (P ≤ .05) within the period of the ambient oxygen tension study.

d

Differences (P ≤ .05) within the period between GSIS studies (oxygenation or hypoxemia) vs ambient oxygen tension data.

e

Treatment differences (P ≤ .05) within steady-state periods for the reverse oxygen tension GSIS studies.

f

Differences (P ≤ .05) between steady state periods within treatment group for the ambient GSIS study.